logo

Ajanta Pharma Q1 PAT Rises 31% to Rs 334 Cr

Authored By PTI | Last Modified: Jul 30, 2026 04:13 PM IST

Stocks in News
AJANTPHARM
₹3,540
0.16%
Ajanta Pharma Q1 PAT Rises 31% to Rs 334 Cr

Open Free Demat Account

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

New Delhi: Ajanta Pharma Ltd on Thursday reported a 31 per cent rise in profit after tax to Rs 334 crore for the first quarter ended June 30.

The company had posted a profit after tax (PAT) of Rs 255 crore in the corresponding period of the last fiscal, Ajanta Pharma said in a regulatory filing.

Its revenue from operations grew 25 per cent to Rs 1,626 crore in the first quarter against Rs 1,303 crore in the year-ago period, it added.

Branded generics revenue in India increased 24 per cent to Rs 509 crore from Rs 409 crore a year ago, the company said.

US generic revenue jumped 57 per cent to Rs 487 crore compared to Rs 310 crore in the year-ago period, it noted.

(Disclaimer: Except for the headline, this article has not been edited by HDFC Sky editorial team and is auto-generated from PTI feed.)

Disclaimer
At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
Disclaimer

At HDFC SKY*, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations.
HDFC SKY from HDFC Securities, one of most trusted trading platforms in India, has been recognized with the *Next-Gen Digi Content Awards 2025-26.

Summarize with AI
Google GeminiChatGPTPerplexity AIAnthropic AIGrok AI

Open Free Demat Account

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Sector: Pharmaceuticals & Biotechnology

AJANTPHARM Share Price

Ajanta Pharma Ltd.

₹3,540

5.60(0.16%)
No Graph
1 Year Returns:-
37.99%
Latest Articles
View More
10 Biggest Milestones in NSE's History
Last Updated: Sep 10, 2026
10 Biggest Milestones in NSE's History
When Is Intraday Profit Credited?
Last Updated: Sep 10, 2026
When Is Intraday Profit Credited?
NSE vs BSE: What is the Difference?
Last Updated: Sep 10, 2026
NSE vs BSE: What is the Difference?
NSE IPO: Who Is Eligible to Apply?
Last Updated: Sep 10, 2026
NSE IPO: Who Is Eligible to Apply?
All You Need to Know About NSE IPO
Last Updated: Sep 10, 2026
All You Need to Know About NSE IPO
Desktop BannerMobile Banner

Invest Anytime, Anywhere

Get it on Google PlayGet it on App Store

Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy